These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19832863)

  • 1. Commentary: Anal cancer - the benefits of evidence-based treatment.
    Hill J
    Colorectal Dis; 2009 Nov; 11(9):914-6. PubMed ID: 19832863
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction chemotherapy followed by radiotherapy in the treatment of anal cancer.
    Lee DH; Kim I; Song HH; Jung JY; Kim DY; Lee KW; Kim TY; Heo DS; Bang YJ; Ha SW; Park JG; Kim NK
    Oncol Rep; 2003; 10(1):101-4. PubMed ID: 12469152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anal cancer: the end of the road for neoadjuvant chemoradiotherapy?
    Glynne-Jones R; Mawdsley S
    J Clin Oncol; 2008 Aug; 26(22):3669-71. PubMed ID: 18519948
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy and chemotherapy in the conservative treatment of anal canal carcinoma.
    Raffetto N; Monaco A; Banelli E
    Anticancer Res; 2008; 28(2B):1335-9. PubMed ID: 18505075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of advanced anal cancer].
    Norum J; Wist E
    Nord Med; 1992; 107(8-9):227-8. PubMed ID: 1408730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of epidermoid anal carcinoma regression after conservative treatment].
    Vorob'ëv GI; Odariuk TS; Orlova LP; Nechushkin MI; Rybakov EG
    Vopr Onkol; 2004; 50(6):663-7. PubMed ID: 15755059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcome of simultaneous radiochemotherapy of anal carcinoma].
    Fraunholz IB; Adamietz IA; Lorenz M; Staib-Sebler E; Böttcher HD
    Zentralbl Chir; 1997; 122(1):39-43. PubMed ID: 9133135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
    J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinomas of the anal canal. Chemotherapy].
    Bugat R
    Ann Gastroenterol Hepatol (Paris); 1991 May; 27(3):133-4. PubMed ID: 1877804
    [No Abstract]   [Full Text] [Related]  

  • 13. High-grade acute organ toxicity as a positive prognostic factor in primary radiochemotherapy for anal carcinoma.
    Wolff HA; Raus I; Jung K; Schüler P; Herrmann MK; Hennies S; Vorwerk H; Hille A; Hess CF; Christiansen H
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1467-78. PubMed ID: 20605354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin-C- or cisplatin-based chemoradiotherapy for anal canal carcinoma: long-term results.
    Olivatto LO; Cabral V; Rosa A; Bezerra M; Santarem E; Fassizoli A; Castro L; Simões JH; Small IA; Ferreira CG
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):490-5. PubMed ID: 20472349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of anal canal cancer.
    Cummings BJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S123-8. PubMed ID: 16399449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma of the anal margin.
    Newlin HE; Zlotecki RA; Morris CG; Hochwald SN; Riggs CE; Mendenhall WM
    J Surg Oncol; 2004 May; 86(2):55-62; discussion 63. PubMed ID: 15112245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anal cancer: one step forward--two steps sideways!
    Glynne-Jones R
    Eur J Cancer; 2009 Nov; 45(16):2728-30. PubMed ID: 19762226
    [No Abstract]   [Full Text] [Related]  

  • 19. Combining cisplatin and mitomycin with radiotherapy in anal carcinoma.
    Crehange G; Bosset M; Lorchel F; Dumas JL; Buffet-Miny J; Puyraveau M; Mercier M; Bosset JF
    Dis Colon Rectum; 2007 Jan; 50(1):43-9. PubMed ID: 17089083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing outcomes of chemoradiation in the management of squamous cell carcinoma of the anal canal.
    McHaffie DR; Kozak KR
    Oncology (Williston Park); 2010 Apr; 24(5):424-7. PubMed ID: 20480741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.